About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Investigating the Effectiveness of Vimida

Investigating the Effectiveness of Vimida

NCT06251518·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Gaia AG

With

Medical School Hamburg
Institut Long-Covid Rostock

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

male, female or non-binary
age ≥ 18
diagnosis of post-COVID-19 fatigue (ICD-10 U08.9, or U09.9 in conjunction with G93.3), secured via a telemedical visit
≥ 3 months since COVID-19 infection that preceded fatigue symptoms
elevated levels of fatigue: cut-off of ≥ 16 on the CFQ-11
consent to participation
sufficient knowledge of the German language

You may not be if

known somatic or psychiatric condition that can explain the fatigue (e.g., cancer, multiple sclerosis, severe depression)
current participation in a multidisciplinary rehabilitation program aimed at ameliorating the consequences of COVID-19

The record

StatusActive not recruiting

PhaseNo phase

Taking part160

StartedFeb 2025

UpdatedJun 18, 2025

Conditions

Long COVID Post COVID-19 Condition

Where1

GAIA
Hamburg, Germany